2012
DOI: 10.1002/bjs.7819
|View full text |Cite
|
Sign up to set email alerts
|

Tissue engineering and the road to whole organs

Abstract: A glimpse into the future of surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

2012
2012
2016
2016

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 63 publications
(121 reference statements)
0
13
0
Order By: Relevance
“…Patterning vascular architecture remains a key challenge in engineering complex, metabolically active tissues such as kidney and liver (9)(10)(11)(12)23). Previously, physical and biochemical means have been used to spatially guide the host angiogenic response in tissue engineered constructs (12-16, 24, 25).…”
Section: Discussionmentioning
confidence: 99%
“…Patterning vascular architecture remains a key challenge in engineering complex, metabolically active tissues such as kidney and liver (9)(10)(11)(12)23). Previously, physical and biochemical means have been used to spatially guide the host angiogenic response in tissue engineered constructs (12-16, 24, 25).…”
Section: Discussionmentioning
confidence: 99%
“…The possibility of using decellularized whole porcine hearts combined with human cells to create viable hearts for transplant is getting closer to reality. 1 Porcine hearts are similar to human hearts in size and anatomy, and the use of porcine heart valves in humans has a long history of success. 123 The development of the decellularization process in rats 12 has been successfully scaled to porcine hearts.…”
Section: Discussionmentioning
confidence: 99%
“…Great progress has been made in culturing patient-specific human cells (e.g., induced pluripotent stem cells [iPSCs]) and the promise of constructing a whole human organ from autologous human cells and decellularized porcine organ scaffolds is getting closer to reality. 1 The two steps in this process are decellularization of porcine organs while preserving the extracellular matrix (ECM) and recellularization with a human patient's cells. To fully develop this technology, there is a need to optimize decellularization processes and equipment to reliably and safely produce acellular hearts in large quantities for combination with human cells.…”
Section: Introductionmentioning
confidence: 99%
“…Although there are many challenges, there is a strong base of public support for these modern RM opportunities to create curative therapeutics for a brighter future in disease management [99][100][101][102].…”
Section: The Future and Challengesmentioning
confidence: 99%